Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Hyperfine Inc (HYPR)

Hyperfine Inc (HYPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 108,829
  • Shares Outstanding, K 97,169
  • Annual Sales, $ 13,560 K
  • Annual Income, $ -35,570 K
  • EBIT $ -37 M
  • EBITDA $ -36 M
  • 60-Month Beta 1.09
  • Price/Sales 9.97
  • Price/Cash Flow N/A
  • Price/Book 2.77

Options Overview Details

View History
  • Implied Volatility 172.51% (+2.74%)
  • Historical Volatility 56.02%
  • IV Percentile 7%
  • IV Rank 3.75%
  • IV High 1,431.48% on 04/14/25
  • IV Low 123.51% on 08/26/25
  • Expected Move (DTE 20) 0.2125 (19.14%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 8
  • Volume Avg (30-Day) 45
  • Put/Call OI Ratio 0.12
  • Today's Open Interest 2,824
  • Open Int (30-Day) 2,666
  • Expected Range 0.8975 to 1.3225

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate -0.09
  • Number of Estimates 1
  • High Estimate -0.09
  • Low Estimate -0.09
  • Prior Year -0.12
  • Growth Rate Est. (year over year) +25.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.0150 +9.36%
on 03/02/26
1.3900 -20.14%
on 03/19/26
+0.0400 (+3.74%)
since 02/27/26
3-Month
0.8694 +27.67%
on 12/31/25
1.3900 -20.14%
on 03/19/26
+0.0500 (+4.72%)
since 12/26/25
52-Week
0.5327 +108.37%
on 05/23/25
2.2200 -50.00%
on 10/15/25
+0.3325 (+42.77%)
since 03/27/25

Most Recent Stories

More News
Horizon Technology Finance Provides $40 Million Loan Facility to Hyperfine

Horizon Technology Finance Corporation (NASDAQ: HRZN) (“Horizon”) (the “Company”), an affiliate of Monroe Capital, today announced it has provided a $40 million loan facility to Hyperfine, Inc....

HYPR : 1.1100 (-0.89%)
HRZN : 4.11 (-4.42%)
Hyperfine, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the...

HYPR : 1.1100 (-0.89%)
Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop®...

HYPR : 1.1100 (-0.89%)
Hyperfine Announces Publication of Breakthrough Clinical Data Demonstrating the Swoop® System’s Enhanced Stroke Detection Capabilities

The largest dataset to date on stroke detection with the Swoop® system demonstrates the ability to identify small strokes rapidly and reliably, reinforcing its clinical value for acute care and emergency...

HYPR : 1.1100 (-0.89%)
Hyperfine Announces NEURO PMR Study Results Showing High Diagnostic Value and Superior Patient Experience in Neurology Clinics

Data presented at the annual American Society of Neuroimaging meeting supports clinical value and broad utility of the portable Swoop® system in outpatient neurology.

HYPR : 1.1100 (-0.89%)
Hyperfine Announces Enrollment of First Patient in Study to Expand Intended Use of the Swoop® System with Contrast Agents

The prospective study is designed to evaluate the feasibility and visualization benefits of contrast-enhanced ultra-low-field portable MRI to support an FDA 510(k) submission.

HYPR : 1.1100 (-0.89%)
Hyperfine Reports Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results

Hyperfine Delivers Quarterly Record Revenue of Approximately $5.3 Million in Q4 2025, Representing Transformative Growth of 54% Compared to Prior Quarter; Exiting 2025 with Approximately $35 Million of...

HYPR : 1.1100 (-0.89%)
Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors

Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced...

HYPR : 1.1100 (-0.89%)
OFIX : 11.50 (-2.46%)
SPNC : 38.45 (unch)
AVNS : 13.52 (-2.38%)
PLSE : 20.57 (-4.33%)
SWAV : 334.75 (-0.02%)
Hyperfine Announces First Peer-Reviewed Publication Demonstrating Significant Economic Benefits of Using the Swoop® AI-Powered Portable MRI System in Acute Hospital Care

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today...

HYPR : 1.1100 (-0.89%)
Hyperfine Announces Regulatory Approval of the Swoop® System in India

India's Central Drugs Standard Control Organization (CDSCO) has approved the Hyperfine Swoop system, opening a major global market. Commercial launch to begin early 2026.

HYPR : 1.1100 (-0.89%)

Business Summary

Hyperfine Inc. is a groundbreaking medical device company which created Swoop(R), first FDA-cleared portable MRI system(TM). Hyperfine Inc., formerly known as HealthCor Catalio Acquisition Corp., is based in GUILFORD, Conn.

See More

Key Turning Points

3rd Resistance Point 1.1833
2nd Resistance Point 1.1567
1st Resistance Point 1.1333
Last Price 1.1100
1st Support Level 1.0833
2nd Support Level 1.0567
3rd Support Level 1.0333

See More

52-Week High 2.2200
Fibonacci 61.8% 1.5755
Fibonacci 50% 1.3764
Fibonacci 38.2% 1.1772
Last Price 1.1100
52-Week Low 0.5327

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.